肺癌
紫杉醇
生物
癌症研究
CpG站点
DNA甲基化
甲基化
癌症
肿瘤科
医学
基因表达
DNA
遗传学
基因
作者
Mingyu Peng,Lin Ye,Li Yang,Xinzhu Liu,Yuhan Chen,Guichuan Huang,Yu Jiang,Yan Wang,Dairong Li,Jin He,Zhu Qiu,Tingxiu Xiang,Shuliang Guo
出处
期刊:Epigenomics
[Future Medicine]
日期:2020-10-01
卷期号:12 (20): 1793-1810
被引量:6
标识
DOI:10.2217/epi-2020-0157
摘要
Aim: To explore the biological functions and clinical significance of CAVIN2 in lung cancer. Materials & methods: Methylation-specific PCR was used to measure promoter methylation of CAVIN2. The function of CAVIN2 was tested by Cell Counting Kit-8, colony formation, Transwell, flow cytometric analysis, acridine orange/ethidium bromide, chemosensitivity assay and xenograft assay. Results: CAVIN2 is significantly downregulated by promoter methylation in lung cancer. CAVIN2 overexpression inhibits lung cancer cell migration and invasion. Furthermore, ectopic expression of CAVIN2 inhibits cell proliferation in vivo and in vitro by inducing G2/M cell cycle arrest, which sensitizes the chemosensitivity of lung cancer cells to paclitaxel and 5-fluorouracil, but not cisplatin. Conclusion: CAVIN2 is a tumor suppressor in non-small-cell lung cancer and can sensitize lung cancer cells to paclitaxel and 5-fluorouracil.
科研通智能强力驱动
Strongly Powered by AbleSci AI